Latest Articles
“It’s No Joke”: People With Endometriosis Are Extra Emotional About Barbara Palvin’s Pregnancy News — So Here’s Why It’s So Important - BuzzFeed
“It’s No Joke”: People With Endometriosis Are Extra Emotional About Barbara Palvin’s Pregnancy News — So Here’s Why It’s So Important BuzzFeed
Published: May 15, 2026, 5:29 p.m.
Pete Davidson and Elsie Hewitt Reportedly Split 5 Months After Welcoming First Child Together - AOL.com
Pete Davidson and Elsie Hewitt Reportedly Split 5 Months After Welcoming First Child Together AOL.com
Published: May 15, 2026, 2:44 p.m.
Pete Davidson and Elsie Hewitt Reportedly Split 5 Months After Daughter's Birth, Insider Says They're "Working on Things" - Yahoo News Singapore
Pete Davidson and Elsie Hewitt Reportedly Split 5 Months After Daughter's Birth, Insider Says They're "Working on Things" Yahoo News Singapore
Published: May 15, 2026, 2:44 p.m.
Did Barbara Palvin have Endometriosis? Medical condition explored after fashion icon announces first pregnancy with Dylan Sprouse at Cannes - Sportskeeda
Did Barbara Palvin have Endometriosis? Medical condition explored after fashion icon announces first pregnancy with Dylan Sprouse at Cannes Sportskeeda
Published: May 15, 2026, 8:43 a.m.
Common Gynecologic Issues in Patients Post-Kidney Transplantation.
Advances in kidney transplantation have transformed survival and quality of life for women with end-stage renal disease, necessitating a focus on long-term health care for this population. Female kidney transplant …
Published: May 15, 2026, midnight
Karyopharm Therapeutics Reports Q1 2026 Results, Advances Selinexor Phase 3 Trials in Myelofibrosis and Endometrial Cancer - Minichart
Karyopharm Therapeutics Reports Q1 2026 Results, Advances Selinexor Phase 3 Trials in Myelofibrosis and Endometrial Cancer Minichart
Published: May 14, 2026, 4:30 p.m.
Maipl Therapeutics Reports Preclinical Progress for MA-4604, a Novel Oral Non-Hormonal Treatment of Endometriosis - Newswise
Maipl Therapeutics Reports Preclinical Progress for MA-4604, a Novel Oral Non-Hormonal Treatment of Endometriosis Newswise
Published: May 14, 2026, 12:40 p.m.
Karyopharm Therapeut Reports Q1 2026: $35.1M Revenue, $29.2M U.S. Product Sales, Net Loss $22.4M - TradingView
Karyopharm Therapeut Reports Q1 2026: $35.1M Revenue, $29.2M U.S. Product Sales, Net Loss $22.4M TradingView
Published: May 14, 2026, 11:33 a.m.
Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment - PR Newswire
Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment PR Newswire
Published: May 14, 2026, 11:30 a.m.
Press Release: Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment - Moomoo
Press Release: Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment Moomoo
Published: May 14, 2026, 11:30 a.m.
Link copied to clipboard!